INSMED Inc
INSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001104506
In the last 90 days, INSMED Inc insiders filed 0 open-market purchases and 7 sales; 667 institutions reported holding it in 13F filings for Q2 2026, worth $23.8B in total; superinvestors Maverick Capital and Duquesne Family Office hold it.
13F holders, Q1 2024
Institutional positions in INSMED Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 288
- +18 vs. Q4 2023
- Shares held
- 150.0M
- +597.0K (+0.4%) vs. Q4 2023
- Total value
- $4.07B
- −$561.4M (−12.1%) vs. Q4 2023
- New holders
- 47
- 97 more added
- Sold out
- 29
- 97 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 667 | $23.8B |
| Q1 2026 | 675 | $35.7B |
| Q4 2025 | 678 | $37.8B |
| Q3 2025 | 566 | $30.3B |
| Q2 2025 | 516 | $21.2B |
| Q1 2025 | 442 | $15.3B |
| Q4 2024 | 439 | $13.3B |
| Q3 2024 | 414 | $13.7B |
| Q2 2024 | 378 | $11.7B |
| Q1 2024 | 288 | $4.07B |
| Q4 2023 | 271 | $4.64B |
| Q3 2023 | 252 | $3.72B |
| Q2 2023 | 223 | $3.09B |
| Q1 2023 | 230 | $2.48B |
| Q4 2022 | 225 | $2.87B |
| Q3 2022 | 238 | $2.74B |
| Q2 2022 | 214 | $2.55B |
| Q1 2022 | 224 | $2.97B |
| Q4 2021 | 214 | $3.36B |
| Q3 2021 | 193 | $3.40B |
| Q2 2021 | 203 | $3.46B |
| Q1 2021 | 199 | $3.63B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding INSMED Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | $0 | 0.00% | −39,743−100.0% | Sold out |
| HN Saltoro Capital, LP | 0 | $0 | 0.00% | −36,550−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −29,565−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −29,481−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −23,044−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −14,026−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −11,758−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −11,010−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −10,199−100.0% | Sold out |
| Vise Technologies, Inc. | 0 | $0 | 0.00% | −8,050−100.0% | Sold out |
| Calton & Associates, Inc. | 0 | $0 | 0.00% | −7,993−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −5,305−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Cambridge Trust Co | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Putnam Investments LLC | – | – | – | – | Not filed |